Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is MARIBAVIR, with a corresponding US DMF Number 42422.
Remarkably, this DMF maintains an Active status since its submission on September 16, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 22, 2025, and payment made on September 12, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II